Cointime

Download App
iOS & Android

Roivant Sciences

company
Funding Round
Post-IPO Equity
Money Raised
$ 200M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
Dainippon Sumitomo Pharma - - - Detail
Eventide - - - Detail
Fidelity Management and Research Company - - - Detail
Palantir Technologies - - - Detail
Patient Square Capital - - - Detail
RTW Investments - - - Detail
SoftBank Capital - - - Detail
Suvretta Capital Management - - - Detail
Viking Global Investors - - - Detail

Historical Financing

Announced Date Round Money Raised Investors
May 1, 2014 Private Equity(PE) $ 93M Dexcel Pharma,QVT Financial,etc. Detail
Nov 13, 2018 Private Equity(PE) $ 200M Dexcel Pharma,Founders Fund,etc. Detail
Jul 13, 2016 Private Equity(PE) $ 500M Viking Global Investors Detail
Aug 9, 2017 Private Equity(PE) $ 1.10B Founders Fund,SoftBank Vision Fund Detail